Skip to main content

Table 7 Annual costs in euro (Finland)

From: Real-world costs of autosomal dominant polycystic kidney disease in the Nordics

Costs in EUR, mean (95% CI)

CKD 1–3 (n = 64)

CKD 4–5 (n = 55)

Dialysis (n = 61)

Transplant (n = 63)

P value

Direct costs

3676 (2223–6190)

5883 (4588–7701)

64,811 (60,460–70,417)

20,305 (16,228–25,166)

<0.0001

Hospitalisations

507 (172–1125)

1309 (515–2611)

5455 (3666–7670)

2557 (1283–4299)

<0.0001

Outpatient care visits

1159 (843–1569)

2057 (1606–2871)

3203 (2329–4230)

3197 (2502–4155)

<0.0001

Primary care visits

237 (117–403)

414 (84–1097)

174 (50–548)

121 (48–265)

.5094

Surgical procedures

249 (15–794)

511 (154–1098)

2562 (1211–5119)

1009 (435–1956)

<0.0001

Diagnostic tests

191 (125–263)

237(166–321)

659 (511–843)

354 (251–496)

<0.0001

Home care/medical assistance

1048 (4–3049)

74 (5–204)

1093 (384–2044)

260 (28–837)

.0002

Routine dialysis care

42,900 (40,609–44,964)

1398 (368–2810)

<0.0001

Haemodialysis transportation

4090 (3184–5080)

13 (0–25)

<0.0001

Drug use

284 (175–419)

1281 (1008–1600)

4675 (4040–5512)

11,396 (9404–13,944)

<0.0001

 Antihypertensives

68 (54–86)

113 (95–132)

73 (60–86)

96 (78–117)

.0020

 Phosphate binders

225 (103–362)

1266 (1006–1554)

65 (15–148)

<0.0001

 ESAs

4 (0–15)

204 (78–361)

1413 (1181–1611)

209 (89–370)

<0.0001

 Analgesics for kidney pain

3 (1–7)

14 (5–30)

12 (4–25)

4 (0–12)

.1329

 Vitamin D analogues

198 (93–335)

689 (516–878)

1318 (1207–1407)

455 (310–620)

<0.0001

 Immunosupressants

440 (26–1076)

10,469 (8516–12,955)

<0.0001

 Other drugs

10 (3–27)

36 (17–61)

154 (126–183)

99 (48–171)

<0.0001

Indirect costs

4863 (2986–7132)

9904 (6738–13,319)

7674 (5195–10,042)

7585 (5125–10,494)

.0925

Productivity loss

4835 (2959–7104)

9667 (6586–13,018)

6783 (4586–8815)

7488 (5058–10,382)

.2742

Informal care

28 (0–83)

237 (79–475)

891 (353–1807)

97 (38–176)

<0.0001

Total costs

8539 (6042–11,631)

15,787 (12,006–20,008)

72,486 (67,053–79,025)

27,890 (22,669–33,722)

<0.0001

  1. P values calculated with Kruskal–Wallis test
  2. EUR euro, ESA erythropoiesis-stimulating agent, CI confidence interval (bias corrected)